evaluate Trim Fast Slimming Capsule
26/12/2014 15:49
As a result they recently submitted it to the FDA for approval and in December of 2010 the FDA committee panel reviewed the positives and negatives about this drug and then voted on their recommendation. The vote was 13 -7 in support of approving it. January 31st 2011 is the date the FDA has set to ultimately evaluate Trim Fast Slimming Capsule and come up with their decision on whether to approve it or not. In most cases the FDA will listen to what their panel has said about a new drug and will follow its advice. However it should be noted that it is not required to do so and theoretically could still not approve Contrave.
The combination of Lida daidaihua Slimming Capsule is an interesting one. Bupropion is an anti-depressant that works differently from many of the regular SSRI anti-depressants but has shown the side effect for many of weight loss. Bupropion has actually been prescribed by some doctors as a weight loss drug already but it was done so "off label" meaning Bupropion has never been approved per say by a regulatory body for this use. Bupropion has also been used to help people stop their addition to smoking/ nicotine. Naltrexone is a medication that is most often prescribed to help patients overcome additions related to drugs and or alcohol. When these two are combined, researchers have found that Naltrexone helps to keep the weight loss going where Bupropion would often start to slow down. The idea of a combination weight loss drug is not a new one, there are a few others out there being tested to treat obesity including Qnexa and Empatic.